@article{9c11462fa4564fa49f44c8177c42116e,
title = "Marginal zone lymphoma: present status and future perspectives",
author = "Cheah, {Chan Y.} and Emanuele Zucca and Davide Rossi and Habermann, {Thomas M.}",
note = "Funding Information: CYC has received fees for consulting and advisory services and honoraria from Roche, Janssen, MSD, Gilead, Ascentage Pharma, AstraZenecca, Lilly, TG therapeutics, Beigene, Novartis, and BMS; research funding from BMS, Roche, Abbvie; and travel expenses from Roche. TMH has participated in data monitoring committees for Seagen and Tess Therapeutics, has sat on scientific advisory boards for Eli Lilly & Co., Morphosys, Incyte, Biegene, and Loxo Oncology; he receives no personal compensation for these activities. His institution receives the compensation. DR receives no personal compensation. His institution has received honoraria from AbbVie, AstraZeneca, and Janssen; and research grants from AbbVie, AstraZeneca, and Janssen. EZ{\textquoteright}s institution has received research support from AstraZeneca, Celgene, Incyte, Janssen, Merck, and Roche; honoraria for advisory boards services from Beigene, Celgene, Incyte Janssen, Merck, Roche, Celltion Healthcare, and Kyte (a Gilead Company); and travel grants from Abbvie and Roche.",
year = "2022",
month = jan,
doi = "10.3324/haematol.2021.278755",
language = "English",
volume = "107",
pages = "35--43",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "1",
}